每經AI快訊，12月(yue)8日，海辰(chen)藥(yao)(yao)(yao)業(ye)發布股(gu)價異(yi)動(dong)公(gong)(gong)告(gao)(gao)，公(gong)(gong)司關注到熊去氧膽酸(suan)預(yu)防新冠病毒感染的研(yan)究報道。經核查，公(gong)(gong)司及子公(gong)(gong)司未(wei)取得熊去氧膽酸(suan)原料藥(yao)(yao)(yao)及制(zhi)劑(ji)的藥(yao)(yao)(yao)品(pin)注冊(ce)批(pi)件，僅在藥(yao)(yao)(yao)品(pin)生(sheng)產(chan)(chan)許可證范圍中含熊去氧膽酸(suan)原料藥(yao)(yao)(yao)，不代表公(gong)(gong)司可以生(sheng)產(chan)(chan)、銷售該藥(yao)(yao)(yao)，截至本公(gong)(gong)告(gao)(gao)披露日，公(gong)(gong)司也(ye)未(wei)有(you)該藥(yao)(yao)(yao)的生(sheng)產(chan)(chan)、銷售行為。